Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders

摘要

The present invention relates to pharmaceutical preparations comprising albumin- fused coagulation factors for the non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders and to a method for increasing the in- vivo recovery after non-intravenous administration of a coagulation factor by fusing it to albumin.